The Wide Trail Design Strategy
نویسندگان
چکیده
We explain the theoretical background of the wide trail design strategy, which was used to design Rijndael, the Advanced Encryption Standard (AES). In order to facilitate the discussion, we introduce our own notation to describe differential and linear cryptanalysis. We present a block cipher structure and prove bounds on the resistance against differential and linear cryptanalysis.
منابع مشابه
Security of a Wide Trail Design
The wide trail design strategy claims to design ciphers that are both efficient and secure against linear and differential cryptanalysis. Rijndael, the AES, was designed along the principles of this strategy. We survey the recent results on Rijndael and examine whether the design strategy has fulfilled its promise.
متن کاملDesign Strategies for ARX with Provable Bounds: Sparx and LAX
We present, for the first time, a general strategy for designing ARX symmetric-key primitives with provable resistance against singletrail differential and linear cryptanalysis. The latter has been a long standing open problem in the area of ARX design. The wide trail design strategy (WTS), that is at the basis of many S-box based ciphers, including the AES, is not suitable for ARX designs due ...
متن کاملSynergistic Effect of Subtoxic-dose Cisplatin and TRAIL to Mediate Apoptosis by Down-regulating Decoy Receptor 2 and Up-regulating Caspase-8, Caspase-9 and Bax Expression on NCI-H460 and A549 Cells
Objective(s): Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis in tumor cells, more than half of tumors including non-small cell lung cancer (NSCLC) exhibit TRAIL-resistance. The purpose of this study was to determine whether subtoxic-dose cisplatin and TRAIL could synergistically enhance apoptosis on NSCLC cells and investigate its under...
متن کاملA novel caspase 8 selective small molecule potentiates TRAIL-induced cell death
Recombinant soluble TRAIL and agonistic antibodies against TRAIL receptors (DR4 and DR5) are currently being created for clinical cancer therapy, due to their selective killing of cancer cells and high safety characteristics. However, resistance to TRAIL and other targeted therapies is an important issue facing current cancer research field. An attractive strategy to sensitize resistant maligna...
متن کاملPreclinical Development Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment
Smac mimetics are being developed as a new class of anticancer therapies. Because the single-agent activity of Smac mimetics is very limited, rational combinations represent a viable strategy for their clinical development. The combination of Smac mimetics with TNF-related apoptosis inducing ligand (TRAIL) may be particularly attractive because of the low toxicity of TRAIL to normal cells and t...
متن کامل